Does HUMAN C1-ESTERASE INHIBITOR Cause Off label use? 1,614 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 1,614 reports of Off label use have been filed in association with HUMAN C1-ESTERASE INHIBITOR (Cinryze). This represents 11.3% of all adverse event reports for HUMAN C1-ESTERASE INHIBITOR.
1,614
Reports of Off label use with HUMAN C1-ESTERASE INHIBITOR
11.3%
of all HUMAN C1-ESTERASE INHIBITOR reports
808
Deaths
964
Hospitalizations
How Dangerous Is Off label use From HUMAN C1-ESTERASE INHIBITOR?
Of the 1,614 reports, 808 (50.1%) resulted in death, 964 (59.7%) required hospitalization, and 784 (48.6%) were considered life-threatening.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for HUMAN C1-ESTERASE INHIBITOR. However, 1,614 reports have been filed with the FAERS database.
What Other Side Effects Does HUMAN C1-ESTERASE INHIBITOR Cause?
Hereditary angioedema (5,572)
No adverse event (1,660)
Drug ineffective (1,426)
Intentional product use issue (1,117)
Product use in unapproved indication (1,003)
Weight increased (897)
Maternal exposure during pregnancy (869)
Pain (822)
Condition aggravated (775)
Swelling (737)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which HUMAN C1-ESTERASE INHIBITOR Alternatives Have Lower Off label use Risk?
HUMAN C1-ESTERASE INHIBITOR vs HUMAN COAGULATION FACTOR VIII/VON WILLEBRAND FACTOR COMPLEX
HUMAN C1-ESTERASE INHIBITOR vs HUMAN CYTOMEGALOVIRUS IMMUNE GLOBULIN
HUMAN C1-ESTERASE INHIBITOR vs HUMAN HEPATITIS B VIRUS IMMUNE GLOBULIN
HUMAN C1-ESTERASE INHIBITOR vs HUMAN IMMUNOGLOBULIN G
HUMAN C1-ESTERASE INHIBITOR vs HUMAN IMMUNOGLOBULIN G\HYALURONIDASE